Levetiracetam Tablet, Film Coated, Extended Release
Product Images NDC 70518-4005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-4005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Clcr 2 (13)

Clcr 2 (13)
FDA Label Image

Clcr 2 (2)

Clcr 2 (2)
FDA Label Image

Levetiracretam Structural Formula (3)

Levetiracretam Structural Formula (3)
FDA Label Image

Figure 1 (4)

Figure 1 (4)
FDA Label Image

Figure 2 (5)

Figure 2 (5)
This is a description of the percentage of patients in a study who were assigned to different treatment groups. The first treatment group received placebo (N=111), the second group received immediate-release levetiracetam tablets at a dosage of 1000 mg/day (N=106), and the third group received immediate-release levetiracetam tablets at a dosage of 2000 mg/day (N=105). The text also indicates that the results for one of the treatment groups were statistically significant compared to the placebo group.*
FDA Label Image

Figure 3 (6)

Figure 3 (6)
This text appears to be a table showing various percentages. It includes percentages ranging from 0% to 45%, with some labeled as "A" and others labeled as "4". It also mentions "Placebo" and "Immediate-release levetiracetam tablets 3000 mg/day" with corresponding sample sizes of 104 and 180, respectively. The text also mentions a statistical significance between the two.*
FDA Label Image

Figure 4 (7)

Figure 4 (7)
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication called LevETIRAcetam Extended-Release 500mg Tablet. The pack contains 30 tablets. The medication is only available with a prescription and the National Drug Code (NDC) is 70518-4005-00. The manufacturer is Salce located in Cranbury, NJ 08512. It is important to keep this medication out of reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F), according to US Pharmacopeia standards. This particular pack has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701. Their contact number is 724.465.8762.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.